Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Anemia

Free Subscription Articles published in Br J Haematol Retrieve available abstracts of 226 articles: HTML format

Single Articles

December 2025
1. KALIBBALA D, Mboizi V, Nambatya G, Murungi S, et al
   Growth measurements in Ugandan children with sickle cell anaemia from a hydroxyurea (hydroxycarbamide) treatment trial relative to unaffected sibling controls.
   Br J Haematol. 2025;207:2539-2549.
   PubMed     Abstract available
   
   
   November 2025
2. BRONS N, Rigas AS, Kaspersen KA, Pedersen OB, et al
   A structural deletion in the 3'UTR of SLC11A2 is associated with altered iron status: Evidence from two large Danish cohorts.
   Br J Haematol. 2025;207:2123-2134.
   PubMed     Abstract available
   
   
   
3. CHE M, Wang C, Li Y, Li L, et al
   A single-centre, real-world study on the efficacy and recovery of inflammatory cytokine levels of C5 complement inhibitor therapy in patients with paroxysmal nocturnal haemoglobinuria.
   Br J Haematol. 2025;207:2109-2117.
   PubMed     Abstract available
   
   
   
4. GUINDO A, Cablay K, Kamate J, MacLean B, et al
   Systematic point-of-care newborn screening for sickle cell disease in rural Mali, West Africa.
   Br J Haematol. 2025;207:2118-2122.
   PubMed     Abstract available
   
   
   
5. WU L, Zhou M, Chen X, Mo W, et al
   Clinical outcomes of modified post-transplantation cyclophosphamide versus granulocyte colony-stimulating factor/anti-thymocyte globulin-based protocol in alternative donor transplantation for severe aplastic anaemia.
   Br J Haematol. 2025;207:2059-2071.
   PubMed     Abstract available
   
   
   
6. SEVANTHINI BR, Hegde S, Sridhar T, Trivedi D, et al
   Short-term risks and benefits of hydroxyurea (hydroxycarbamide)-induced transfusion independence in patients with beta-thalassaemia syndromes.
   Br J Haematol. 2025;207:2196-2199.
   PubMed     Abstract available
   
   
   
7. DWOMOH D, Abankwah DNY, Benneh-Akwasi Kuma AA, Quartey J, et al
   Effectiveness of hydroxyurea (hydroxycarbamide) in a national sickle cell disease programme in Ghana.
   Br J Haematol. 2025;207:2099-2108.
   PubMed     Abstract available
   
   
   October 2025
8. MUSALLAM KM, Vitrano A, Inzerillo A, Di Maggio R, et al
   Impact of lifetime anaemia and iron control on outcomes in beta-thalassaemia: Data from the longitudinal de-LIGHT study.
   Br J Haematol. 2025;207:1578-1588.
   PubMed     Abstract available
   
   
   
9. REVEL-VILK S, Ben-Ami T, Constantini N
   Is it time to offer routine screening for iron deficiency in healthy adolescent females?
   Br J Haematol. 2025;207:1242-1247.
   PubMed     Abstract available
   
   
   September 2025
10. CHANG M, Semakula D, Little JA, Kanter J, et al
    Grandchildren of GRNDaD: Shifts in disease-modifying therapy at the adolescent transition in sickle cell disease.
    Br J Haematol. 2025;207:1070-1075.
    PubMed     Abstract available
    
    
    
11. SHANGGUAN S, Cui X, Li J, Li N, et al
    Alu-mediated FANCD2 exonic deletion contributes to Fanconi anaemia.
    Br J Haematol. 2025;207:1076-1084.
    PubMed     Abstract available
    
    
    
12. CHAMBLISS C, Manci E, Fields E, Bueno J, et al
    Characterizing pregnancy outcomes in a humanized mouse model of sickle cell disease.
    Br J Haematol. 2025;207:813-823.
    PubMed     Abstract available
    
    
    
13. HAJJAJ OI, Callum J, Shehata N, Farrell A, et al
    Laboratory assessment of fetomaternal haemorrhage and Rh immune globulin management: Canadian practice and scoping review.
    Br J Haematol. 2025;207:723-736.
    PubMed     Abstract available
    
    
    
14. LEUNG WY, Lee TY, Hwang YY, Lee JT, et al
    Iron overload and morbidities in Chinese with non-transfusion-dependent thalassaemia.
    Br J Haematol. 2025;207:1058-1069.
    PubMed     Abstract available
    
    
    August 2025
15. ZHANG L, Liu Z, Zhao X, Hu B, et al
    Efficacy and safety of HRS-5965 monotherapy in complement inhibitor-naive patients with paroxysmal nocturnal haemoglobinuria.
    Br J Haematol. 2025;207:571-581.
    PubMed     Abstract available
    
    
    
16. TEAWTRAKUL N, Jetsrisuparb A, Pongudom S, Chansung K, et al
    Survival and thalassaemia-related complications in HbE/beta-thalassaemia and alpha-thalassaemia: A 10-year longitudinal study in Thailand.
    Br J Haematol. 2025;207:552-560.
    PubMed     Abstract available
    
    
    
17. LEE JW, Jang JH, Chiba S, Yoon SS, et al
    Romiplostim with ciclosporin A in patients with aplastic anaemia naive to immunosuppressive therapy: A phase 2/3 study.
    Br J Haematol. 2025;207:582-590.
    PubMed     Abstract available
    
    
    
18. AFZALI-HASHEMI L, Franse M, Baas KPA, Schrantee A, et al
    Assessment of neurocognitive functioning in sickle cell disease and thalassaemia and the association with silent cerebral infarcts, cerebral haemodynamics and oxygen metabolism.
    Br J Haematol. 2025;207:561-570.
    PubMed     Abstract available
    
    
    July 2025
19. LOH J, Kuo KHM, Georgescu I, Wang S, et al
    Risk factors for immediate postpartum sickle cell disease-specific maternal morbidity.
    Br J Haematol. 2025;207:225-234.
    PubMed     Abstract available
    
    
    
20. WILSON SR, Noubouossie D, Little JA, Karafin MS, et al
    Real-world assessment of acute red cell exchange for stroke in sickle cell disease.
    Br J Haematol. 2025;207:217-224.
    PubMed     Abstract available
    
    
    
21. DIAW M, Coly MS, Charlot K, Gallou-Guyot M, et al
    Physical activity, vaso-occlusive crises and pain in patients with sickle cell anaemia in Senegal.
    Br J Haematol. 2025;207:206-216.
    PubMed     Abstract available
    
    
    
22. SANTINI V, Consagra A
    How to use luspatercept and erythropoiesis-stimulating agents in low-risk myelodysplastic syndrome.
    Br J Haematol. 2025;207:15-26.
    PubMed     Abstract available
    
    
    June 2025
23. KUO KHM, Layton DM, Lal A, Vichinsky EP, et al
    Long-term efficacy and safety of mitapivat in non-transfusion-dependent alpha- or beta-thalassaemia: An open-label phase 2 study.
    Br J Haematol. 2025;206:1764-1773.
    PubMed     Abstract available
    
    
    
24. VISTICA SAMPINO E, Bonal DM, Chorzalska A, Morgan J, et al
    Alterations in the humoral immunophenotype in sickle cell disease.
    Br J Haematol. 2025;206:1774-1785.
    PubMed     Abstract available
    
    
    
25. RICCHI P
    The double edge of erythropoietic modulation in thalassaemia.
    Br J Haematol. 2025;206:1879-1880.
    PubMed     Abstract available
    
    
    
26. HARJU T, Raiskila S, Lohi O, Jarvela L, et al
    Increased incidence of autoimmune haemolytic anaemia with paroxysmal cold haemoglobinuria features in paediatric cases in a changing viral environment post-COVID-19 pandemic.
    Br J Haematol. 2025;206:1872-1876.
    PubMed     Abstract available
    
    
    
27. PALANI CD, Smith A, Cao X, Li B, et al
    Cholesterol-conjugated miR-29b induces fetal haemoglobin expression via gamma-globin promoter demethylation in the Townes mouse model for sickle cell anaemia.
    Br J Haematol. 2025;206:1786-1795.
    PubMed     Abstract available
    
    
    
28. ZAIDEL B, Garland S, Merkeley H
    Acute splenomegaly, haemolysis, and thrombocytopenia following luspatercept initiation in a patient with transfusion-dependent thalassaemia: A case report.
    Br J Haematol. 2025;206:1806-1810.
    PubMed     Abstract available
    
    
    
29. BRANDSEN RP, Diederen RMH, Klaassen I, Veldthuis M, et al
    The role of red blood cell characteristics and viscosity in sickle cell retinopathy and maculopathy.
    Br J Haematol. 2025;206:1796-1805.
    PubMed     Abstract available
    
    
    
30. MAEDA T, Matsuda A, Kanda J, Kawabata H, et al
    Comparison of severe aplastic anaemia and lower risk hypoplastic myelodysplastic neoplasms: Critical role of megakaryocyte count in distinguishing aplastic anaemia from myelodysplastic neoplasms.
    Br J Haematol. 2025;206:1689-1698.
    PubMed     Abstract available
    
    
    
31. JACOBS JW, Amorim L, Pirenne F, Tayou C, et al
    The wider perspective: Barriers and recommendations for transfusion support for patients with sickle cell disease in low- and middle-income countries.
    Br J Haematol. 2025;206:1585-1592.
    PubMed     Abstract available
    
    
    
32. BALCIUNIENE J, Yilmaz S, Chonat S, Grace RF, et al
    Real-world insights from a cohort of approximately 2000 individuals who were analysed using a freely available next-generation sequencing anaemia screening programme.
    Br J Haematol. 2025;206:1853-1856.
    PubMed     Abstract available
    
    
    May 2025
33. MACLEAN B, Fuller J, Lim J, Dugan C, et al
    Greater prevalence of anaemia and heavy menstrual bleeding reported in women of reproductive age in the United Kingdom compared to Australia.
    Br J Haematol. 2025;206:1479-1484.
    PubMed     Abstract available
    
    
    
34. DELICOU S, Manganas K, Diamantidis MD, Venou TM, et al
    Comparative analysis of mortality patterns and treatment strategies in thalassaemia and sickle cell disease patients: A 12-year study.
    Br J Haematol. 2025;206:1466-1478.
    PubMed     Abstract available
    
    
    
35. PRINCE EJ, Scott JL, Nwankwoala O, Ali-Houchens L, et al
    A young adult clinic to support integration into adult sickle cell disease care: If you build it, they will come.
    Br J Haematol. 2025;206:1458-1465.
    PubMed     Abstract available
    
    
    April 2025
36. HOVING V, Donker AE, Schols SEM, Swinkels DW, et al
    How I treat iron-refractory iron deficiency anaemia-An expert opinion-based treatment guidance for children and adults.
    Br J Haematol. 2025;206:1067-1076.
    PubMed     Abstract available
    
    
    
37. METAFUNI E, Brioschi FA, Patriarca A, Leoni C, et al
    Real-world evidence of pegcetacoplan in patients with paroxysmal nocturnal haemoglobinuria: A nationwide Italian study.
    Br J Haematol. 2025;206:1246-1249.
    PubMed     Abstract available
    
    
    
38. CORSIA A, Joseph L, Beeker N, Manceau S, et al
    Maternal and perinatal outcomes of sickle cell disease in pregnancy: A nationwide study in France.
    Br J Haematol. 2025;206:1218-1227.
    PubMed     Abstract available
    
    
    
39. ENACHE A, Carty SA, Babushok DV
    Origins of T-cell-mediated autoimmunity in acquired aplastic anaemia.
    Br J Haematol. 2025;206:1035-1053.
    PubMed     Abstract available
    
    
    
40. SINHA U, Setty S, Pilon C, Brown JJ, et al
    Systemic lupus erythematosus-associated autoantibodies in sickle cell disease: Spontaneous emergence in a patient and in transgenic sickle mice.
    Br J Haematol. 2025;206:1213-1217.
    PubMed     Abstract available
    
    
    March 2025
41. DE LIGT LA, Gaartman AE, Konte K, Thakoerdin S, et al
    Plasma inflammatory and angiogenic protein profiling of patients with sickle cell disease.
    Br J Haematol. 2025;206:954-964.
    PubMed     Abstract available
    
    
    
42. SCHECHTER AN
    Sickle cell anaemia therapy in 2025.
    Br J Haematol. 2025;206:842-845.
    PubMed     Abstract available
    
    
    
43. LONGORIA JN, Howell KE, Porter JS, Treadwell M, et al
    Depression, sleep and pain affect instrumental activities of daily living through cognitive functioning in adults with sickle cell disease: A report from the Sickle Cell Disease Implementation Consortium.
    Br J Haematol. 2025;206:944-953.
    PubMed     Abstract available
    
    
    
44. LI H, Sachdev V, Tian X, Nguyen ML, et al
    A machine learning-based workflow for predicting transplant outcomes in patients with sickle cell disease.
    Br J Haematol. 2025;206:919-923.
    PubMed     Abstract available
    
    
    February 2025
45. MAGGIO A, Napolitano M, Taher AT, Bou-Fakhredin R, et al
    Reframing thalassaemia syndrome as a benign haematopoietic stem cell disorder.
    Br J Haematol. 2025;206:464-477.
    PubMed     Abstract available
    
    
    
46. ZHANG J, Sun J, Huai W, Tang J, et al
    Elucidating loss-of-function mechanisms of monoallelic EPAS1 mutations underlying congenital hypoplastic anaemia in a paediatric anaemia cohort.
    Br J Haematol. 2025;206:585-595.
    PubMed     Abstract available
    
    
    
47. EL HOSS S, Bazoum H
    From old to new: Repurposed drugs in the battle towards curing sickle cell disease.
    Br J Haematol. 2025;206:795-797.
    PubMed     Abstract available
    
    
    
48. BHAT V, Potdar AA, Yu GK, Gibson G, et al
    Impact of hydroxycarbamide treatment on the whole-blood transcriptome in sickle cell disease.
    Br J Haematol. 2025;206:713-720.
    PubMed     Abstract available
    
    
    
49. GURNARI C, Visconte V
    Dissecting the genomic traits and clinical course of secondary myelodysplastic syndrome following aplastic anaemia: A milestone.
    Br J Haematol. 2025;206:790-791.
    PubMed     Abstract available
    
    
    
50. QI J, Wang T, Wang M, He P, et al
    Comparative study of the diversity of amino acids on human leucocyte antigen class II molecules in patients with acquired aplastic anaemia.
    Br J Haematol. 2025;206:735-748.
    PubMed     Abstract available
    
    
    
51. RAZ S, Koren A, Bogdanova AY, Gassmann M, et al
    Memantine treatment in sickle cell disease: A 1-year study of its effects on cognitive functions and neural processing.
    Br J Haematol. 2025;206:689-702.
    PubMed     Abstract available
    
    
    
52. SONGDEJ D, Teawtrakul N, Laoaroon N, Komvilaisak P, et al
    Impact of HbE mutation on the clinical severity of HbH disease: A multicentre study from Thailand.
    Br J Haematol. 2025;206:703-712.
    PubMed     Abstract available
    
    
    January 2025
53. GE S, Ali S, Haldane V, Bekdache C, et al
    An approach to Hemequity: Identifying the barriers and facilitators of iron deficiency reduction strategies in low- to middle-income countries.
    Br J Haematol. 2025 Jan 6. doi: 10.1111/bjh.19984.
    PubMed     Abstract available
    
    
    
54. KHAN AA, Laas CE, Brewin JN, Potter V, et al
    Development of a novel test of splenic function for use in a clinical diagnostic laboratory.
    Br J Haematol. 2025;206:320-330.
    PubMed     Abstract available
    
    
    
55. GEHRIE EA, Booth GS
    Contextualizing prophylactic red blood cell antigen matching in the lifelong care of sickle cell disease and thalassaemia patients.
    Br J Haematol. 2025;206:382-384.
    PubMed     Abstract available
    
    
    
56. GALADANCI NA, Kanter J
    Avascular necrosis in sickle cell disease needs more definitive treatment options.
    Br J Haematol. 2025;206:385-386.
    PubMed     Abstract available
    
    
    
57. PIECHNIK SK, Polzella P, Shah A, Vera-Aviles M, et al
    Myocardial iron intake following intravenous iron therapy with ferric carboxymaltose is sustained at 1 year despite recurrence of iron deficiency.
    Br J Haematol. 2025;206:349-352.
    PubMed     Abstract available
    
    
    
58. NOGUER M, Berthon P, Makowski C, Messonnier LA, et al
    Impaired physical ability in patients with transfusion-dependent beta-thalassaemia: Can regular physical activity be a countermeasure?
    Br J Haematol. 2025;206:86-93.
    PubMed     Abstract available
    
    
    
59. WOLF J, Blais-Normandin I, Bathla A, Keshavarz H, et al
    Red cell specifications for blood group matching in patients with haemoglobinopathies: An updated systematic review and clinical practice guideline from the International Collaboration for Transfusion Medicine Guidelines.
    Br J Haematol. 2025;206:94-108.
    PubMed     Abstract available
    
    
    
60. KOCHHAR M, McGann PT
    Sickle cell disease in India: Not just a mild condition.
    Br J Haematol. 2025;206:380-381.
    PubMed     Abstract available
    
    
    
61. SETH T, Udupi S, Jain S, Bhatwadekar S, et al
    Burden of vaso-occlusive crisis, its management and impact on quality of life of Indian sickle cell disease patients.
    Br J Haematol. 2025;206:296-309.
    PubMed     Abstract available
    
    
    
62. CASALE M, Toro G, Porcelli F, Quota A, et al
    Long-term outcomes of avascular necrosis in sickle cell disease using joint-specific patient-reported outcome measures: Results from a multicentre study.
    Br J Haematol. 2025;206:310-319.
    PubMed     Abstract available
    
    
    December 2024
63. LOTH G, Dumke CCK, Muratori RR, Pelegrina PD, et al
    Haematopoietic cell transplantation for 106 infants and preschoolers with acquired and inherited bone marrow failures.
    Br J Haematol. 2024;205:2387-2402.
    PubMed     Abstract available
    
    
    
64. SEGBEFIA CI, Smart LR, Stuber SE, Amissah-Arthur KN, et al
    Baseline characteristics of Ghanaian children and adults enrolled in PIVOT, a randomised clinical trial of hydroxyurea in HbSC disease in sub-Saharan Africa.
    Br J Haematol. 2024;205:2470-2480.
    PubMed     Abstract available
    
    
    November 2024
65. COSTA S, Minucci A, Kumawat A, De Bonis M, et al
    Pathogenic G6PD variants: Different clinical pictures arise from different missense mutations in the same codon.
    Br J Haematol. 2024;205:1985-1994.
    PubMed     Abstract available
    
    
    
66. CINTHO OZAHATA M, Guo Y, Gomes I, Malta B, et al
    Genetic variants associated with white blood cell count amongst individuals with sickle cell disease.
    Br J Haematol. 2024;205:1974-1984.
    PubMed     Abstract available
    
    
    
67. ELSHERIF L, Tang Y, Patillo KL, Wichlan D, et al
    Association of biomarkers of endothelial function, coagulation activation and kidney injury with persistent albuminuria in sickle cell anaemia.
    Br J Haematol. 2024;205:1963-1973.
    PubMed     Abstract available
    
    
    
68. GURNARI C, Lima ACM, Pagliuca S
    HLA-lacking clones in aplastic anaemia: Adaptive or maladaptive?
    Br J Haematol. 2024;205:1681-1682.
    PubMed     Abstract available
    
    
    
69. MARIN V, Huguenin Y, Bessi L, Weinmann L, et al
    Beta-thalassaemia intermedia due to a complex alpha-globin rearrangement and a heterozygous beta thalassaemia mutation.
    Br J Haematol. 2024;205:1959-1962.
    PubMed     Abstract available
    
    
    
70. ZAIMOKU Y, Sakai K, Tsuji N, Hosomichi K, et al
    Haematopoietic regeneration by HLA-A*0206-deficient clones in severe aplastic anaemia without definitive immunosuppressive treatment.
    Br J Haematol. 2024;205:1995-1999.
    PubMed     Abstract available
    
    
    October 2024
71. GUPTA CL, Jaganathasamy N, Madkaikar M
    Microbiome in sickle cell disease: Pathophysiology and therapeutic insights.
    Br J Haematol. 2024;205:1279-1287.
    PubMed     Abstract available
    
    
    
72. GILTON M, Fernandes H, Martinez C, Leverger G, et al
    Association of paediatric autoimmune cytopenia and inflammatory bowel disease suggests a common genetic origin.
    Br J Haematol. 2024;205:1508-1515.
    PubMed     Abstract available
    
    
    
73. VALENTINI CG, Teofili L, Gehrie E
    Iron metabolism in sickle cell disease patients undergoing chronic red blood cell exchange: A delicate homeostasis in balance.
    Br J Haematol. 2024;205:1257-1259.
    PubMed     Abstract available
    
    
    
74. CONNES P, Nader E
    Could oxygen gradient ektacytometry help to detect sickle cell trait carriers at risk for kidney disorders or exercise-related complications?
    Br J Haematol. 2024;205:1260-1261.
    PubMed     Abstract available
    
    
    
75. RAMSAY Z, Ali A, Grant J, Asnani M, et al
    Exploring the role of viscosity-vaso-occlusion and haemolysis-endothelial dysfunction in pain sensitization among Jamaicans with sickle cell disease.
    Br J Haematol. 2024;205:1570-1580.
    PubMed     Abstract available
    
    
    
76. M ROSS J, Forte S, Mercure-Corriveau N, Lemay AS, et al
    Automated red blood cell exchange with a post-procedure haematocrit targeted at 34% in the chronic management of sickle cell disease.
    Br J Haematol. 2024;205:1556-1564.
    PubMed     Abstract available
    
    
    
77. ELLSWORTH P, Pawlinski IJ, Sielaty R, Ilich A, et al
    Hypertonicity and/or acidosis induce marked rheological changes under hypoxic conditions in sickle trait red blood cells.
    Br J Haematol. 2024;205:1565-1569.
    PubMed     Abstract available
    
    
    
78. KATO S, Chagi K, Takagi Y, Hidaka M, et al
    Machine/deep learning-assisted hemoglobin level prediction using palpebral conjunctival images.
    Br J Haematol. 2024;205:1590-1598.
    PubMed     Abstract available
    
    
    
79. LEE JM, Kim HS, Yoo J, Lee J, et al
    Genomic insights into inherited bone marrow failure syndromes in a Korean population.
    Br J Haematol. 2024;205:1581-1589.
    PubMed     Abstract available
    
    
    September 2024
80. CATELLA J, Turpin E, Connes P, Nader E, et al
    Impaired microvascular function in patients with sickle cell anemia and leg ulcers improved with healing.
    Br J Haematol. 2024 Sep 24. doi: 10.1111/bjh.19785.
    PubMed     Abstract available
    
    
    
81. STRAUSS JD, Brown DW, Zhou W, Dagnall C, et al
    Telomere length and clonal chromosomal alterations in peripheral blood of patients with severe aplastic anaemia.
    Br J Haematol. 2024;205:1180-1187.
    PubMed     Abstract available
    
    
    
82. PRABAHRAN A, Durrani J, Coelho-Da Silva J, Shalhoub R, et al
    Safety and efficacy of immunosuppressive therapy for elderly patients with severe aplastic anaemia.
    Br J Haematol. 2024;205:1170-1179.
    PubMed     Abstract available
    
    
    
83. ZHOU LY, Derebail VK, Desai PC, Elsherif L, et al
    Persistent albuminuria and chronic kidney disease in adults with sickle cell anaemia: Results from a multicenter natural history study.
    Br J Haematol. 2024;205:1159-1169.
    PubMed     Abstract available
    
    
    
84. SADAF A, Dong M, Pfeiffer A, Korpik J, et al
    A pharmacokinetic-pharmacodynamic analysis of l-glutamine for the treatment of sickle cell disease: Implications for understanding the mechanism of action and evaluating response to therapy.
    Br J Haematol. 2024;205:1147-1158.
    PubMed     Abstract available
    
    
    
85. NKOY AB, Mumaka FM, Ngonde A, Mafumba SK, et al
    Relevance of repeated analyses of albuminuria and glomerular filtration rate in African children with sickle cell anaemia.
    Br J Haematol. 2024;205:1137-1146.
    PubMed     Abstract available
    
    
    
86. ZHOU X, Wagner V, Scheller L, Stanojkovska E, et al
    Changes in T-cell subsets, preexisting cytopenias and hyperferritinaemia correlate with cytopenias after BCMA targeted CAR T-cell therapy in relapsed/refractory multiple myeloma: Results from a prospective comprehensive biomarker study.
    Br J Haematol. 2024;205:999-1010.
    PubMed     Abstract available
    
    
    August 2024
87. GLENTHOJ A, Grace RF, Lander C, van Beers EJ, et al
    Comorbidities and complications in adult and paediatric patients with pyruvate kinase deficiency: Analysis from the Peak Registry.
    Br J Haematol. 2024;205:613-623.
    PubMed     Abstract available
    
    
    
88. KATZ BZ, Karny S
    Pursuing the elusive footsteps of malaria in peripheral blood smears utilizing artificial intelligence.
    Br J Haematol. 2024;205:414-415.
    PubMed     Abstract available
    
    
    
89. SHARMA A, Kumar A, Rawat K, Vij S, et al
    Novel TMPRSS6 variants and their impact on iron-refractory iron deficiency anaemia in pregnancy: A North Indian genotype phenotype study.
    Br J Haematol. 2024;205:686-698.
    PubMed     Abstract available
    
    
    
90. RECH JS, Cohen A, Bartolucci P, Santin A, et al
    Shift in emergency department utilization by frequent attendees with sickle cell disease during the COVID-19 pandemic: A multicentre cohort study.
    Br J Haematol. 2024;205:463-472.
    PubMed     Abstract available
    
    
    
91. SEGBEFIA C, Luchtman-Jones L
    Seeing haemoglobin SC: Challenging the misperceptions.
    Br J Haematol. 2024;205:404-405.
    PubMed     Abstract available
    
    
    
92. NELSON M, Noisette L, Pugh N, Gordeuk V, et al
    The clinical spectrum of HbSC sickle cell disease-not a benign condition.
    Br J Haematol. 2024;205:653-663.
    PubMed     Abstract available
    
    
    
93. MOYSIS E, Brown BJ, Shokunbi W, Manescu P, et al
    Leveraging deep learning for detecting red blood cell morphological changes in blood films from children with severe malaria anaemia.
    Br J Haematol. 2024;205:699-710.
    PubMed     Abstract available
    
    
    
94. SHANDLEY LM, Fasano RM, Spencer JB, Mertens AC, et al
    The impact of sickle cell disease and its treatment on ovarian reserve in reproductive-aged Black women.
    Br J Haematol. 2024;205:674-685.
    PubMed     Abstract available
    
    
    
95. ROSSI M, Belinga S, Tolo A, Diop S, et al
    Determinants of the haemoglobin level in patients with sickle cell disease living in sub-Saharan Africa: Major impact of the country of residence and independent effects of leucocyte and platelet counts and haemolysis.
    Br J Haematol. 2024;205:664-673.
    PubMed     Abstract available
    
    
    
96. PIOLATTO A, Gaglioti CM, Tesio N, Clemente MG, et al
    Deferasirox film-coated tablet-associated ulcerative colitis: An emerging pattern in thalassemia patients?
    Br J Haematol. 2024;205:719-721.
    PubMed    
    
    
    
97. HAN J, Zhang X, Shah BN, Saraf SL, et al
    Alkaline phosphatase as a marker for painful vaso-occlusive events and other acute complications in sickle cell disease.
    Br J Haematol. 2024;205:716-718.
    PubMed    
    
    
    July 2024
98. CATELLA J, Guillot N, Nader E, Skinner S, et al
    Controversies in the pathophysiology of leg ulcers in sickle cell disease.
    Br J Haematol. 2024;205:61-70.
    PubMed     Abstract available
    
    
    
99. GOK V, Leblebisatan G, Gurlek Gokcebay D, Guler S, et al
    Pyruvate kinase deficiency in 29 Turkish patients with two novel intronic variants.
    Br J Haematol. 2024;205:236-242.
    PubMed     Abstract available
    
    
    
100. CHEMINET G, Corbasson A, Charmettan M, Namaoui W, et al
     Assessment of fatigue in adult patients with sickle cell disease: Use of the functional assessment of chronic illness therapy-Fatigue (FACIT-fatigue) questionnaire.
     Br J Haematol. 2024;205:335-342.
     PubMed     Abstract available
     
     
     
101. MAYRAND L, Elie J, Pinhas Y, Rignault-Bricard R, et al
     Sputum interleukin-6 level as a marker of severity during acute chest syndrome in children with sickle cell disease.
     Br J Haematol. 2024;205:329-334.
     PubMed     Abstract available
     
     
     
102. PLAZA-FLORIDO A, Liem RI, Haddad F, Radom-Aizik S, et al
     Whole-blood transcriptome analysis reveals distinct gene expression signatures in paediatric patients with sickle cell anaemia before and after exercise.
     Br J Haematol. 2024;205:320-328.
     PubMed     Abstract available
     
     
     
103. ZHANG L, Chang M, Liu C, Xu Y, et al
     A case of de novo -alpha(3.7) thalassaemia and the utility of CATSA for detecting de novo mutations in thalassaemia.
     Br J Haematol. 2024;205:360-363.
     PubMed    
     
     
     
104. PADENIYA P, Premawardhena A
     Obesity, liver steatosis and metabolic syndrome: The hidden enemies in transfusion-dependent thalassaemia.
     Br J Haematol. 2024;205:28-29.
     PubMed     Abstract available
     
     
     
105. RUIZ MA, Zhang X, Mansilla MA, Zahr RS, et al
     Prevalence of kidney health genetic variants in adults with sickle cell nephropathy.
     Br J Haematol. 2024;205:316-319.
     PubMed     Abstract available
     
     
     
106. KIM DH, Hong J, Shin DY, Kim I, et al
     Phase II trial of posaconazole prophylaxis during anti-thymocyte globulin treatment for aplastic anaemia and hypoplastic myelodysplastic syndrome.
     Br J Haematol. 2024;205:356-359.
     PubMed    
     
     
     
107. HANDS K, Daru J, Evans C, Kotze A, et al
     Identification and management of preoperative anaemia in adults: A British Society for Haematology Guideline update.
     Br J Haematol. 2024;205:88-99.
     PubMed     Abstract available
     
     
     June 2024
108. GUARNERA L, Visconte V
     The metabolic fuel of paroxysmal nocturnal haemoglobinuria.
     Br J Haematol. 2024;204:2162-2164.
     PubMed     Abstract available
     
     
     
109. SHAH FT, Nicolle S, Garg M, Pancham S, et al
     Guideline for the management of conception and pregnancy in thalassaemia syndromes: A British Society for Haematology Guideline.
     Br J Haematol. 2024;204:2194-2209.
     PubMed     Abstract available
     
     
     
110. RICCHI P, Pistoia L, Positano V, Spasiano A, et al
     Liver steatosis in patients with transfusion-dependent thalassaemia.
     Br J Haematol. 2024;204:2458-2467.
     PubMed     Abstract available
     
     
     
111. ZACCHEDDU E, Zappu A, Barella S, Clemente MG, et al
     Unplanned pregnancy in women with beta-thalassaemia treated with luspatercept.
     Br J Haematol. 2024;204:2505-2507.
     PubMed    
     
     
     
112. CHEN Y, Liu H, Wang C, Chen W, et al
     The histone demethylase JMJD1C regulates CPS1 expression and promotes the proliferation of paroxysmal nocturnal haemoglobinuria clones through cell metabolic reprogramming.
     Br J Haematol. 2024;204:2468-2479.
     PubMed     Abstract available
     
     
     
113. DAVILA J, O'Brien SH, Mitchell WB, Manwani D, et al
     Evaluating thromboprophylaxis in the sickle cell disease population: Navigating the evidence gap.
     Br J Haematol. 2024;204:2184-2193.
     PubMed     Abstract available
     
     
     May 2024
114. PHONGPAO K, Pholngam N, Chokchaichamnankit D, Nuamsee K, et al
     Proteomic profiling of circulating beta-thalassaemia/haemoglobin E extra-cellular vesicles reveals that association with immunoglobulin induces membrane vesiculation.
     Br J Haematol. 2024;204:2025-2039.
     PubMed     Abstract available
     
     
     
115. CASABIANCA M, Gauthier A, Nader E, Cannas G, et al
     Red blood cell senescence and vascular function in patients with hereditary spherocytosis with and without splenectomy.
     Br J Haematol. 2024;204:e41-e44.
     PubMed    
     
     
     
116. HAGRY J, Monnet X, Mekontso-Dessap A, Chantalat C, et al
     Comprehensive assessment, pain and ventilatory management during acute complications of adult sickle cell disease: A clinical practice survey in French intensive care units.
     Br J Haematol. 2024;204:e37-e40.
     PubMed    
     
     
     
117. MANARA R, Brotto D, Barillari MR, Costa G, et al
     Hearing loss in beta-thalassaemia: An Italian multicentre case-control study.
     Br J Haematol. 2024;204:2016-2024.
     PubMed     Abstract available
     
     
     
118. LIPTON JM
     Understanding complex disease-related mechanisms: Rational therapies for Diamond-Blackfan anaemia.
     Br J Haematol. 2024;204:1598-1599.
     PubMed     Abstract available
     
     
     
119. TOMBUL Z, Bahaj W, Ozturk M, Patel B, et al
     Ahemolytic PNH (white cell PNH): Clinical features and implications of a distinct phenotype of paroxysmal nocturnal haemoglobinuria.
     Br J Haematol. 2024;204:2121-2124.
     PubMed    
     
     
     
120. ROGER G, Denormandie P, Gobe T, Azzolina D, et al
     Left ventricular global longitudinal strain and acute myocardial injury in patients with sickle cell disease admitted to the intensive care unit for vaso-occlusive crisis.
     Br J Haematol. 2024;204:2007-2015.
     PubMed     Abstract available
     
     
     
121. DUNCAN BB, Lotter JL, Superata J, Barranta ME, et al
     Treatment of refractory/relapsed Diamond-Blackfan anaemia with eltrombopag.
     Br J Haematol. 2024;204:2077-2085.
     PubMed     Abstract available
     
     
     
122. BIANCHI C, Margot H, Fernandes H, Pasquet M, et al
     Autoimmune cytopenia and Kabuki syndrome in paediatrics: Insights in 11 patients.
     Br J Haematol. 2024;204:1899-1907.
     PubMed     Abstract available
     
     
     
123. UKONMAANAHO EM, Dell'Anna S, Hakonen A, Wartiovaara-Kautto U, et al
     Biallelic hexokinase 1 (HK1) variants causative of non-spherocytic haemolytic anaemia: A case series with emphasis on the HK1 promoter variant and literature review.
     Br J Haematol. 2024;204:2040-2048.
     PubMed     Abstract available
     
     
     
124. GIORGETTI A, Nyilima S, Stoffel NU, Moretti D, et al
     Stable iron ((58)Fe) isotopic measurements in Kenyan toddlers during 3 months of iron supplementation demonstrate that half of the iron absorbed is lost.
     Br J Haematol. 2024;204:2057-2065.
     PubMed     Abstract available
     
     
     
125. MAEDA T, Matsuda A, Kanda J, Kawabata H, et al
     Clinical impact and characteristics of erythroid dysplasia in adult aplastic anaemia: Results from a multicentre registry.
     Br J Haematol. 2024;204:2086-2096.
     PubMed     Abstract available
     
     
     
126. NEYER PJ, Kabore B, Nakas CT, Diallo S, et al
     Increased erythroferrone levels in malarial anaemia.
     Br J Haematol. 2024;204:2066-2070.
     PubMed     Abstract available
     
     
     April 2024
127. ARCANJO GS, Souza MB, Domingos IF, Pereira-Martins DA, et al
     BMP6 and VDR gene polymorphisms are associated with osteonecrosis in a sickle cell anaemia cohort.
     Br J Haematol. 2024;204:1507-1514.
     PubMed     Abstract available
     
     
     
128. CHANG A, Wilson SR, Morris S, Wichlan D, et al
     Nocturnal hypoxaemia is common in adults with sickle cell anaemia.
     Br J Haematol. 2024;204:1495-1499.
     PubMed     Abstract available
     
     
     
129. JACOBS JW, Sharma D, Stephens LD, Figueroa Villalba CA, et al
     Thrombosis risk with haemoglobin C trait and haemoglobin C disease: A systematic review.
     Br J Haematol. 2024;204:1500-1506.
     PubMed     Abstract available
     
     
     
130. KUNVARJEE B, Contreras Yametti GP, Blouin AG, Linder GE, et al
     Donor-specific antibody desensitization with daratumumab prior to haematopoietic cell transplant for sickle cell disease: A case report.
     Br J Haematol. 2024;204:1540-1544.
     PubMed    
     
     
     March 2024
131. EBEA-UGWUANYI PO, Vidyasagar S, Connor JR, Frazer DM, et al
     Oral iron therapy: Current concepts and future prospects for improving efficacy and outcomes.
     Br J Haematol. 2024;204:759-773.
     PubMed     Abstract available
     
     
     
132. KULASEKARARAJ A, Cavenagh J, Dokal I, Foukaneli T, et al
     Guidelines for the diagnosis and management of adult aplastic anaemia: A British Society for Haematology Guideline.
     Br J Haematol. 2024;204:784-804.
     PubMed     Abstract available
     
     
     
133. LEE GM, Batchvarova M, Delahunty M, Boateng L, et al
     Sickle red blood cells directly activate neutrophils.
     Br J Haematol. 2024;204:e28-e30.
     PubMed    
     
     
     
134. JONASSAINT CR, Parchuri E, O'Brien JA, Lalama CM, et al
     Mental health, pain and likelihood of opioid misuse among adults with sickle cell disease.
     Br J Haematol. 2024;204:1029-1038.
     PubMed     Abstract available
     
     
     
135. HANSEN DL, Maquet J, Lafaurie M, Moller S, et al
     Primary autoimmune haemolytic anaemia is associated with increased risk of ischaemic stroke: A binational cohort study from Denmark and France.
     Br J Haematol. 2024;204:1072-1081.
     PubMed     Abstract available
     
     
     
136. EARLY ML, Raja M, Luo A, Solow M, et al
     Blood pressure thresholds for the diagnosis of hypertensive disorders of pregnancy in sickle cell disease.
     Br J Haematol. 2024;204:1039-1046.
     PubMed     Abstract available
     
     
     
137. KISALI EP, Iversen PO, Makani J
     Low vitamin B(12) blood levels in sickle cell disease: Data from a large cohort study in Tanzania.
     Br J Haematol. 2024;204:1047-1053.
     PubMed     Abstract available
     
     
     
138. STEINBERG-SHEMER O, Yacobovich J, Noy-Lotan S, Dgany O, et al
     Biallelic hypomorphic variants in CAD cause uridine-responsive macrocytic anaemia with elevated haemoglobin-A2.
     Br J Haematol. 2024;204:1067-1071.
     PubMed     Abstract available
     
     
     
139. LIU H, Ding K, Zhang W, Xing L, et al
     A pilot study of orelabrutinib treatment in three cases of refractory/relapsed autoimmune haemolytic anaemia/Evans syndrome.
     Br J Haematol. 2024;204:1082-1085.
     PubMed     Abstract available
     
     
     
140. MUNARETTO V, Corti P, Bertoni E, Tripodi SI, et al
     Acute chest syndrome in children with sickle cell disease: Data from a national AIEOP cohort identify priority areas of intervention in a hub-and-spoke system.
     Br J Haematol. 2024;204:1061-1066.
     PubMed     Abstract available
     
     
     February 2024
141. WARE RE, Quinn CT
     The bold promise of gene therapy for sickle cell disease.
     Br J Haematol. 2024;204:381-382.
     PubMed    
     
     
     
142. STEENSMA DP
     Revisiting the first reported case of aplastic anaemia.
     Br J Haematol. 2024;204:455-458.
     PubMed     Abstract available
     
     
     
143. KATAGIRI T, Iwasaki H, Fujieda A, Kasashima S, et al
     A case of hepatitis-associated aplastic anaemia following living-donor liver transplantation for fulminant hepatitis showing loss of heterozygosity in the 6p chromosome in the affected liver.
     Br J Haematol. 2024;204:623-627.
     PubMed     Abstract available
     
     
     
144. HUNT RC, Kimchi-Sarfaty C
     A synonymous variant is unmasked in thalassaemia.
     Br J Haematol. 2024;204:399-401.
     PubMed     Abstract available
     
     
     
145. KHWAJA J, Japzon N, Gabriel M, Raju K, et al
     Cold agglutinin disease and cryoglobulinaemia: A frequent coexistence with clinical impact.
     Br J Haematol. 2024;204:e21-e24.
     PubMed    
     
     
     
146. EARLY ML, Luo A, Solow M, Matusiak K, et al
     Natural history of blood pressure in sickle cell disease pregnancy.
     Br J Haematol. 2024;204:658-667.
     PubMed     Abstract available
     
     
     
147. CHAKRAVORTY S, Drasar E, Kaya B, Kesse-Adu R, et al
     UK Haemoglobin Disorders Peer Review: A Quality Standards-based review programme for sickle cell disease and thalassaemia.
     Br J Haematol. 2024;204:668-676.
     PubMed     Abstract available
     
     
     
148. SISLER I, McClish DK, Villella A, Valrie C, et al
     Impact of community health workers on quality of life in adolescents and young adults with sickle cell disease: The SHIP-HU study.
     Br J Haematol. 2024;204:649-657.
     PubMed     Abstract available
     
     
     
149. GORIVALE M, Sawant P, Kargutkar N, Hariharan P, et al
     When a synonymous mutation breaks the silence in a thalassaemia patient.
     Br J Haematol. 2024;204:677-682.
     PubMed     Abstract available
     
     
     January 2024
150. OYARBIDE U, Crane GM, Corey SJ
     The metabolic basis of inherited neutropenias.
     Br J Haematol. 2024;204:45-55.
     PubMed     Abstract available
     
     
     
151. PETERS C
     Haematopoietic stem cell transplantation in children with sickle cell disease: Still to do?
     Br J Haematol. 2024;204:22-23.
     PubMed     Abstract available
     
     
     
152. DANIEL Y, Henthorn J
     Lessons learnt in the screening and diagnosis of haemoglobinopathies.
     Br J Haematol. 2024;204:68-73.
     PubMed     Abstract available
     
     
     
153. SHOOK LM, Ware RE
     Screening for haemoglobin disorders: One size may not fit all.
     Br J Haematol. 2024;204:26-28.
     PubMed     Abstract available
     
     
     
154. CSEH A, Galimard JE, de la Fuente J, Isgro A, et al
     Busulfan-fludarabine- or treosulfan-fludarabine-based conditioning before allogeneic HSCT from matched sibling donors in paediatric patients with sickle cell disease: A study on behalf of the EBMT Paediatric Diseases and Inborn Errors Working Parties.
     Br J Haematol. 2024;204:e1-e5.
     PubMed     Abstract available
     
     
     
155. GUINDO A, Cisse Z, Keita I, Desmonde S, et al
     Potential for a large-scale newborn screening strategy for sickle cell disease in Mali: A comparative diagnostic performance study of two rapid diagnostic tests (SickleScan(R) and HemotypeSC(R)) on cord blood.
     Br J Haematol. 2024;204:337-345.
     PubMed     Abstract available
     
     
     
156. ALLALI S, Marquant F, Rignault-Bricard R, Taylor M, et al
     Oral famotidine reduces the plasma level of soluble P-selectin in children with sickle cell disease.
     Br J Haematol. 2024;204:346-351.
     PubMed     Abstract available
     
     
     December 2023
157. PIZZO A, Porter JS, Carroll Y, Burcheri A, et al
     Provider prescription of hydroxyurea in youth and adults with sickle cell disease: A review of prescription barriers and facilitators.
     Br J Haematol. 2023;203:712-721.
     PubMed     Abstract available
     
     
     
158. MISHKIN AD, Prince EJ, Leimbach EJ, Mapara MY, et al
     Psychiatric comorbidities in adults with sickle cell disease: A narrative review.
     Br J Haematol. 2023;203:747-759.
     PubMed     Abstract available
     
     
     November 2023
159. GREEN NS, Rosano C, Bangirana P, Opoka R, et al
     Neurofilament light chain: A potential biomarker for cerebrovascular disease in children with sickle cell anaemia.
     Br J Haematol. 2023;203:460-467.
     PubMed     Abstract available
     
     
     
160. BANDINI P, Borras N, Fernandez Mellid E, Martin-Fernandez L, et al
     First description of bone marrow failure syndrome in Spain caused by mutations in the ERCC6L2 gene.
     Br J Haematol. 2023;203:e102-e107.
     PubMed    
     
     
     
161. STEWART GW, Gibson JS, Rees DC
     The cation-leaky hereditary stomatocytosis syndromes: A tale of six proteins.
     Br J Haematol. 2023;203:509-522.
     PubMed     Abstract available
     
     
     
162. NOVAK W, Berner J, Svaton M, Jimenez-Heredia R, et al
     Evans syndrome caused by a deleterious mutation affecting the adaptor protein SASH3.
     Br J Haematol. 2023;203:678-683.
     PubMed     Abstract available
     
     
     
163. SCULLY M, Rayment R, Clark A, Westwood JP, et al
     A British Society for Haematology Guideline: Diagnosis and management of thrombotic thrombocytopenic purpura and thrombotic microangiopathies.
     Br J Haematol. 2023;203:546-563.
     PubMed     Abstract available
     
     
     
164. FERMO E, Zaninoni A, Vercellati C, Marcello AP, et al
     When alpha spectrin null alleles meet low expression alpha spectrin polymorphisms.
     Br J Haematol. 2023;203:684-687.
     PubMed    
     
     
     October 2023
165. ALADJIDI N, Pincez T, Rieux-Laucat F, Nugent D, et al
     Paediatric-onset Evans syndrome: Breaking away from refractory immune thrombocytopenia.
     Br J Haematol. 2023;203:28-35.
     PubMed     Abstract available
     
     
     
166. RANQUE B, Diaw M, Dembele AK, Lapoumeroulie C, et al
     Association of haemolysis markers, blood viscosity and microcirculation function with organ damage in sickle cell disease in sub-Saharan Africa (the BIOCADRE study).
     Br J Haematol. 2023;203:319-326.
     PubMed     Abstract available
     
     
     
167. ALSULTAN A, Abujoub R, Alsudairy R, Memon S, et al
     Human leucocyte antigen-matched related haematopoietic stem cell transplantation using low-dose cyclophosphamide, fludarabine and thymoglobulin in children with severe aplastic anaemia.
     Br J Haematol. 2023;203:255-263.
     PubMed     Abstract available
     
     
     
168. HEBBEL RP, Milbauer L, Wei P
     A novel promoter of endothelial dysfunction in African Americans: Relevance to sickle cell anaemia.
     Br J Haematol. 2023;203:e71-e73.
     PubMed    
     
     
     September 2023
169. ZHANG Y, Xie H, Liang G, Qin Y, et al
     A novel gain-of-function PIP4K2A mutation elevates the expression of beta-globin and aggravates the severity of alpha-thalassemia.
     Br J Haematol. 2023;202:1018-1023.
     PubMed     Abstract available
     
     
     
170. NANNELLI C, Bosman A, Cunningham J, Dugue PA, et al
     Genetic variants causing G6PD deficiency: Clinical and biochemical data support new WHO classification.
     Br J Haematol. 2023;202:1024-1032.
     PubMed     Abstract available
     
     
     
171. DE ALCANTARA PEDRO PP, Castro CHM, Pinheiro MM, Goncalves LM, et al
     Vertebral fractures and low lean mass in young men with sickle cell disease: Lack of association with bone mineral density and clinical characteristics.
     Br J Haematol. 2023;202:e46-e49.
     PubMed    
     
     
     
172. HAN J, Saraf SL, Gordeuk VR
     Vaccination in sickle cell disease: Immunocompromised or immunocompetent?
     Br J Haematol. 2023;202:916-918.
     PubMed     Abstract available
     
     
     
173. ESPERTI S, Nader E, Boisson C, Carin R, et al
     Mitochondria retention in mature RBCs from haemoglobin SC patients.
     Br J Haematol. 2023;202:e36-e38.
     PubMed    
     
     
     
174. KNIGHT-MADDEN J, King L, Asnani M, Skyers N, et al
     Needs assessment in adults and parents of children living with sickle cell disease in Jamaica.
     Br J Haematol. 2023;202:e31-e35.
     PubMed    
     
     
     
175. NAKAHARA H, Cheedarla N, Verkerke HP, Cheedarla S, et al
     Enhanced IgG immune response to COVID-19 vaccination in patients with sickle cell disease.
     Br J Haematol. 2023;202:937-941.
     PubMed     Abstract available
     
     
     
176. GUPTA A, Gooda R, Marouf R
     Pseudo-Gaucher cells in a splenectomised Beta-Thalassemia patient.
     Br J Haematol. 2023;202:911.
     PubMed    
     
     
     
177. ZOLLER H, Wagner S, Schaefer B
     What is wrong in doing good?
     Br J Haematol. 2023;202:1089-1090.
     PubMed     Abstract available
     
     
     
178. ASHER S, Shah R, Ings S, Horder J, et al
     Haematopoietic stem cell mobilisation followed by high-dose chemotherapy and autologous stem cell transplantation for patients with sickle cell disease and myeloma.
     Br J Haematol. 2023;202:1224-1227.
     PubMed    
     
     
     
179. DASARI S, Tse W, Wang J
     Real-world evidence of incidence and outcomes of aplastic anaemia following administration of immune checkpoint inhibitors.
     Br J Haematol. 2023;202:1205-1208.
     PubMed     Abstract available
     
     
     
180. CHU Z, Cushway T, Wong M, Lim KX, et al
     Incidence and predictors of hypophosphataemia after ferric carboxymaltose use-A 3-year experience from a single institution in Singapore.
     Br J Haematol. 2023;202:1199-1204.
     PubMed     Abstract available
     
     
     
181. MANGANAS K, Delicou S, Xydaki A, Kourakli A, et al
     Predisposing factors for advanced liver fibrosis in patients with sickle cell disease.
     Br J Haematol. 2023;202:1192-1198.
     PubMed     Abstract available
     
     
     
182. JACOBS JW, Ding JJ, Tormey CA, Abels EA, et al
     Where do they go? The clinical conundrum of warm autoantibodies and their inability to cause haemolytic disease of the foetus and newborn.
     Br J Haematol. 2023;202:1213-1215.
     PubMed    
     
     
     August 2023
183. ELSHERIF L, Kanthakumar P, Afolabi J, Stratton AF, et al
     Urinary angiotensinogen is associated with albuminuria in adults with sickle cell anaemia.
     Br J Haematol. 2023;202:669-673.
     PubMed     Abstract available
     
     
     
184. GIBSON JS, Stewart GW
     A critical role for altered red cell cation permeability in pathogenesis of sickle cell disease and other haemolytic anaemias.
     Br J Haematol. 2023;202:462-464.
     PubMed     Abstract available
     
     
     
185. NADER E, Conran N, Leonardo FC, Hatem A, et al
     Piezo1 activation augments sickling propensity and the adhesive properties of sickle red blood cells in a calcium-dependent manner.
     Br J Haematol. 2023;202:657-668.
     PubMed     Abstract available
     
     
     
186. HAMANI S, Lioure B, Nicolae A, Lipsker D, et al
     A Rare Cause of Refractory Anaemia hidden between Folds.
     Br J Haematol. 2023;202:712.
     PubMed    
     
     
     
187. JOLY P, Nader E, Ketels F, Boisson C, et al
     Effects of pyruvate kinase activators on red blood cell properties in sickle cell disease.
     Br J Haematol. 2023;202:e27-e30.
     PubMed    
     
     
     
188. ZHANG X, Han J, Shah BN, Saraf SL, et al
     Platelet count decline and high neutrophil count within the first day of admission for painful sickle cell vaso-occlusive episodes predict severe complications.
     Br J Haematol. 2023;202:e20-e23.
     PubMed    
     
     
     
189. MARTIN OY, Margulies S, Speller-Brown B, Majumdar S, et al
     The evolution of the COVID-19 pandemic in paediatric patients with sickle cell disease: From Alpha to Omicron.
     Br J Haematol. 2023;202:479-484.
     PubMed     Abstract available
     
     
     July 2023
190. RAI MP, Lee EJ, Bussel JB
     Maintenence rituximab following induction in autoimmune cytopenias.
     Br J Haematol. 2023;202:153-158.
     PubMed     Abstract available
     
     
     
191. HAROUN E, Dutta D, Lim SH
     Effects of GBT1118, a voxelotor analog, on intestinal pathophysiology in sickle cell disease.
     Br J Haematol. 2023;202:184-194.
     PubMed     Abstract available
     
     
     
192. FERRONE FA
     More of the same? Voxelotor spawns a successor, but on what success does it build?
     Br J Haematol. 2023;202:13-15.
     PubMed    
     
     
     
193. DUFU K, Alt C, Strutt S, Partridge J, et al
     GBT021601 improves red blood cell health and the pathophysiology of sickle cell disease in a murine model.
     Br J Haematol. 2023;202:173-183.
     PubMed     Abstract available
     
     
     June 2023
194. SHETH S, Taher AT, Coates TD, Kattamis A, et al
     Management of luspatercept therapy in patients with transfusion-dependent beta-thalassaemia.
     Br J Haematol. 2023;201:824-831.
     PubMed     Abstract available
     
     
     
195. WU J, Wang J, Tang N, Wang X, et al
     An atypical patient with bone marrow failure syndrome-2 without microcephaly and learning disability in a Chinese family.
     Br J Haematol. 2023;201:e50-e53.
     PubMed    
     
     
     
196. LIN Y, Del Giudice ME, Kron A, Meirovich H, et al
     A pilot feasibility trial of daily versus every other day oral iron supplementation in patients with iron deficiency anaemia.
     Br J Haematol. 2023;201:1000-1004.
     PubMed    
     
     
     
197. PENG Y, Liang L, Zhang H, Liu H, et al
     Single-cell profiling of ineffective erythropoiesis in a mouse model of beta-thalassaemia intermedia.
     Br J Haematol. 2023;201:982-994.
     PubMed     Abstract available
     
     
     
198. BAIN BJ, Daniel Y, Henthorn J, de la Salle B, et al
     Significant haemoglobinopathies: A guideline for screening and diagnosis: A British Society for Haematology Guideline: A British Society for Haematology Guideline.
     Br J Haematol. 2023;201:1047-1065.
     PubMed     Abstract available
     
     
     
199. JACOBS JW, Stephens LD, Allen ES, Binns TC, et al
     Epidemiological and clinical features, therapeutic strategies and outcomes in patients with hyperhaemolysis: A systematic review.
     Br J Haematol. 2023;201:1025-1032.
     PubMed     Abstract available
     
     
     
200. GENDREAU S, Cecchini J, Perier F, Razazi K, et al
     Effect of high-flow oxygen therapy on regional oxygen saturation during vaso-occlusive pain crisis: An observational study.
     Br J Haematol. 2023;201:e58-e61.
     PubMed    
     
     
     
201. TAKASAKI K, Friedman DF, Uter S, Vege S, et al
     Variant RHD alleles and Rh immunization in patients with sickle cell disease.
     Br J Haematol. 2023;201:1220-1228.
     PubMed     Abstract available
     
     
     
202. LI J, Wang Y, Zhang Y, Zhang X, et al
     Haematopoietic stem cell transplantation for hepatitis-associated aplastic anaemia and non-hepatitis-associated aplastic anaemia: A propensity score-matched analysis.
     Br J Haematol. 2023;201:1179-1191.
     PubMed     Abstract available
     
     
     
203. CHEMINET G, Brunetti A, Khimoud D, Ranque B, et al
     Acute chest syndrome in adult patients with sickle cell disease: The relationship with the time to onset after hospital admission.
     Br J Haematol. 2023;201:1229-1238.
     PubMed     Abstract available
     
     
     
204. JARISCH A, Salzmann-Manrique E, Soerensen J, Sach G, et al
     Donor-type red blood cell transfusion to deplete isoagglutinins prior to allogeneic stem cell transplantation from ABO major incompatible bone marrow donors.
     Br J Haematol. 2023;201:1159-1168.
     PubMed     Abstract available
     
     
     May 2023
205. GAVILLET M, Rufer N, Grandoni F, Rizzi M, et al
     Successful outcome of pregnancy post-allogeneic stem cell transplant despite severe RH1 alloimmunization: A case report.
     Br J Haematol. 2023;201:581-584.
     PubMed    
     
     
     
206. PICCIN A, Magzoub I, Hervig T
     The 'scintilla' starting vaso-occlusion in sickle cell disease.
     Br J Haematol. 2023;201:379-380.
     PubMed    
     
     
     
207. AN R, Man Y, Cheng K, Zhang T, et al
     Sickle red blood cell-derived extracellular vesicles activate endothelial cells and enhance sickle red cell adhesion mediated by von Willebrand factor.
     Br J Haematol. 2023;201:552-563.
     PubMed     Abstract available
     
     
     
208. TOWERMAN AS, Guilliams KP, Guerriero R, Shinawi MS, et al
     Hyperammonemia and acute liver failure associated with deferasirox in two adolescents with sickle cell disease.
     Br J Haematol. 2023;201:e30-e33.
     PubMed    
     
     
     
209. LUNATI-ROZIE A, Janin A, Faubert E, Nony S, et al
     Use of minigene assays as a useful tool to confirm the pathogenic role of intronic variations of the ANK1 gene: Report of two cases of hereditary spherocytosis.
     Br J Haematol. 2023;201:e46-e49.
     PubMed    
     
     
     
210. TENNENBAUM J, Volle G, Pouchot J, Joseph L, et al
     Increased risk of venous thromboembolism in splenectomized patients with sickle cell disease.
     Br J Haematol. 2023;201:793-796.
     PubMed    
     
     
     April 2023
211. SICA M, Barone F, Nannelli C, Ricci P, et al
     The long-acting anti-C5 ravulizumab results in C3 binding to PNH red cells similar to its parental molecule eculizumab.
     Br J Haematol. 2023;201:e1-e4.
     PubMed    
     
     
     
212. KAPUR R
     The potential of metabolomics as a predictive guide for clinical management in autoimmunity against red blood cells.
     Br J Haematol. 2023;201:13-14.
     PubMed     Abstract available
     
     
     
213. ROSSI M, Pirenne F, Le Roux E, Smaine D, et al
     Delayed haemolytic transfusion reaction in paediatric patients with sickle cell disease: A retrospective study in a French national reference centre.
     Br J Haematol. 2023;201:125-132.
     PubMed     Abstract available
     
     
     
214. WANG YM, Loveless M, Miller E, Nelson AS, et al
     Phenotypes of adults with Fanconi anaemia.
     Br J Haematol. 2023;201:133-139.
     PubMed     Abstract available
     
     
     
215. RABELO IB, Chiba AK, Moritz E, D'Amora P, et al
     Metabolomic profile in patients with primary warm autoimmune haemolytic anaemia.
     Br J Haematol. 2023;201:140-149.
     PubMed     Abstract available
     
     
     
216. JACOB M, Kawadler JM, Murdoch R, Ahmed M, et al
     Brain volume in Tanzanian children with sickle cell anaemia: A neuroimaging study.
     Br J Haematol. 2023;201:114-124.
     PubMed     Abstract available
     
     
     
217. KOREN A
     The continuing global challenges of treating patients with beta-thalassemia.
     Br J Haematol. 2023;201:183-184.
     PubMed     Abstract available
     
     
     
218. JACOBS JW, Binns TC, Abels E, Tormey CA, et al
     Autoimmune haemolytic anaemia secondary to babesiosis: A review of reported cases and description of a novel association with cold antibody-mediated haemolytic anaemia.
     Br J Haematol. 2023;201:364-369.
     PubMed    
     
     
     
219. SUTRA DEL GALY A, Willems L, D'Aveni M, Pautas C, et al
     Haemolytic paroxysmal nocturnal haemoglobinuria in patients with myeloid neoplasms: A rare association with specific therapeutic implications.
     Br J Haematol. 2023;201:e16-e20.
     PubMed    
     
     
     
220. HOKLAND P, Daar S, Khair W, Sheth S, et al
     Thalassaemia-A global view.
     Br J Haematol. 2023;201:199-214.
     PubMed     Abstract available
     
     
     
221. DONZE C, Benoit A, Thuret I, Faust C, et al
     beta-Thalassemia in childhood: Current state of health in a high-income country.
     Br J Haematol. 2023;201:334-342.
     PubMed     Abstract available
     
     
     
222. EARLEY EJ, Kelly S, Fang F, Alencar CS, et al
     Genome-wide association study of early ischaemic stroke risk in Brazilian individuals with sickle cell disease implicates ADAMTS2 and CDK18 and uncovers novel loci.
     Br J Haematol. 2023;201:343-352.
     PubMed     Abstract available
     
     
     
223. JACOBS JW, Booth GS, Guarente J, Schlafer D, et al
     Autoimmune haemolytic anaemia and immune thrombocytopenia following SARS-CoV-2 and non-SARS-CoV-2 vaccination: 32 Years of passive surveillance data.
     Br J Haematol. 2023;201:227-233.
     PubMed     Abstract available
     
     
     March 2023
224. TSITSIKAS DA, Rowe S, Bosch A, Hui C, et al
     Addition of plasma exchange to red cell exchange improves outcomes of fat embolism syndrome in sickle cell disease.
     Br J Haematol. 2023;200:e50-e52.
     PubMed    
     
     
     
225. MCKEAGUE S, Peake N, Lovelock D, Chow J, et al
     Acquired HbH disease diagnosed by HbA1c capillary electrophoresis.
     Br J Haematol. 2023;200:687.
     PubMed    
     
     
     
226. KOEHL B, Claude L, Reminy K, Tarer V, et al
     Erythrocyte type 1 equilibrative nucleoside transporter expression in sickle cell disease and sickle cell trait.
     Br J Haematol. 2023;200:812-820.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Anemia is free of charge.